Background
Patients hospitalized with serious acute illness face critical decisions about their medical care and use of life sustaining treatments. In neurologic illness such as stroke, patient decisional capacity is commonly impaired and decisions regarding interventions such as resuscitation, ventilation, or artificial nutrition are made by a surrogate decision maker who is typically a family member or trusted loved one. However, many surrogates are unprepared to make these decisions for their loved ones [
1‐
3]. They may have difficulty determining what the patient would want, and as a result, may suffer long-term adverse psychological outcomes [
3‐
6].
Decision support tools have been shown to improve the quality of decision making and reduce decisional conflict in multiple clinical settings [
7]. However, only a limited number of tools have been developed to support decision-making on life sustaining treatment during an acute hospitalization [
6,
8‐
13], and none have been specifically developed for stroke decision making. To address these gaps, we developed a web-based decision support tool, called
Understanding Stroke: A Guide for Family Decision Makers, designed to help surrogate decision makers set the overall goals of treatment for a loved one hospitalized with an acute stroke. Here, we describe the development process, key features, and initial usability testing for this tool.
Results
A total of four focus groups were held that included 8 physicians, 1 nurse, 5 occupational or physical therapists, 1 social worker, 5 stroke survivors, and 6 family members. When asked about the presentation of prognostic calculator results, some providers, patients, and family members expressed that some people will like numbers, while others may find it distressing and unhelpful. It was suggested that a preface would be needed to warn surrogates about the potential emotional distress it may evoke and also to offer the option to not view the personalized numeric prognosis. Some stroke family members expressed the desire for the prognostic model to show outcomes beyond 3 months. However, due to limitations of the available source data, we were unable to accommodate this request. To clarify to the user that continued improvement is possible beyond 3 months, the following sentence was added – “While people can continue to improve for a year or more after a stroke, doctors have found that most recovery happens in the first 3 to 6 months.”
When asked about the best graphical format for presentation, pie charts were overwhelmingly favored by patients, surrogates, and providers alike. Other options with positive responses included the vertical bar chart, icon array [
29], and the horizontal stacked bar chart (primarily preferred by providers due to its common presence in stroke literature). Although icon arrays are a commonly recommended format to present numeric information [
30,
31], most participants did not favor icon arrays, in part due the complexity of displaying multiple outcome categories. The study team ultimately decided to display both a pie chart and a horizontal bar chart, with the option to toggle between the two options depending on surrogate preference.
A plain language description of each level of the modified Rankin Scale was created to accompany the prognostic information to help with interpretation of the prognostic model. Due to the study targeting a moderate to severe stroke population, and to minimize the number of displayed categories, mRS scores of 0–2 were combined to become a single category of “mild disability or better”. The other scores were maintained as distinct categories – “moderate disability”, “moderately severe disability”, and “severe disability”, for mRS 3, 4, and 5, respectively. Examples of residual symptoms were listed to help family members understand the range of possible outcomes. The descriptions also included examples on the types of assistance they may need, e.g., not able to live alone, need help with daily activities, etc. The full description of text used for the modified Rankin scale is shown in Table
1.
Table 1
Plain language description of the modified Rankin Scale
0–2 | Mild Disability or Better | • May have some mild symptoms of stroke, such as - Weakness - Numbness - Changes in thinking or speaking • Able to live on their own and manage daily activities (bathing, shopping, preparing or getting meals and managing finances) |
3 | Moderate Disability | • Not able to do all of the activities they could do before the stroke • May have difficulty thinking or speaking • May need help with some daily activities (bathing, shopping, preparing or getting meals, managing finances) • Able to walk without help from another person, but may need a cane or a walker |
4 | Moderately Severe Disability | • Need help with some daily activities (eating, bathing, dressing, toileting) • May have more severe difficulty thinking or speaking • Not able to walk without help from another person • May need a wheelchair • Not able to live alone |
5 | Severe Disability | • Need help with most or all activities (eating, bathing, walking) • Not able to sit up in bed without help • Not able to move from a bed to a chair without help • Do not have full control of bladder or bowel function • Not able to live alone • Need constant nursing care and usually live in a long-term nursing facility |
Given the multitude of life-sustaining treatment decisions that a stroke surrogate decision maker may face (e.g. intubation, resuscitation, feeding tube),
Understanding Stroke was designed to frame the decision as setting the overall goals of treatment rather than on any individual treatment or procedure. The overall goals of treatment were adapted from prior work and includes Life-Prolonging Treatment, Basic Treatment, and Comfort Measures Only [
32]. Information about the three possible goals of treatment are summarized for surrogates as shown in Table
2. This section on making treatment decisions also includes education on what it means to be a surrogate decision maker and the importance of focusing on what their loved one would want [
33].
Table 2
Summary of goals of treatment
Cardiopulmonary resuscitation (CPR) and defibrillation (electric shock to the heart) | X | | |
Breathing machine (ventilator) | X | | |
Intensive Care Unit (ICU) care | X | | |
Intravenous (IV) therapy | X | X | Sometimes used for pain |
Hospitalization | X | X | Sometimes |
Physical, occupational, or speech therapy | X | X | |
Pain relief | X | X | X |
A total of 24 participants were recruited (22 patients or family members, and 2 non-physician members of the stroke team) for the card sorting exercise to assist in developing the values clarification component. One item regarding the ability to drive was ranked as the least important by participants and was eliminated. No new items were added by the participants. The final list consists of 13 items shown in Table
3, which was made into a checklist for the surrogate to check off. The stem of the exercise was “My loved one might consider stopping treatment to extend life (and choose comfort measures only) if, for a few months or more, they” An additional option of “None of the above” was added for surrogates who think their family member would want to extend life despite all of these circumstances.
Table 3
Values clarification exercise
Were not able to talk, but could still engage in non-verbal communication | ☐ |
Had difficulty thinking of words or understanding others | ☐ |
Were not able to breathe without the help of a machine | ☐ |
Were not able to participate in important hobbies, social, or religious activities | ☐ |
Had difficulty thinking clearly or making decisions (e.g. needed help managing finances) | ☐ |
Needed help from another person to eat, bathe, or take care of basic bathroom needs | ☐ |
Were not able to live on their own or take care of themselves | ☐ |
Needed a walker or wheelchair to move around | ☐ |
Had to stay in bed constantly | ☐ |
Needed a feeding tube to get nutrition | ☐ |
Had a lot of discomfort or pain | ☐ |
Had to stay in a nursing home or rehabilitation facility | ☐ |
Could not move one side of their body | ☐ |
Two rounds of usability testing were conducted. The first was done 6 months prior to making the tool available to participants to allow time to make changes, and the second was 1 month prior for a final check. The combined participants across both rounds included 2 stroke survivors, 5 family members, and 2 stroke providers. In the task directive section, most people were able to find a specific section when asked. For anything that was more difficult to find, interface and navigation enhancements were made to the tool to improve the visibility of these items to the user. Results from the modified SUS show that most people felt the website was easy to navigate and interact with. A small number of participants felt they had to learn a lot of things before they could start using the website in the first round, or that using the tool was at a moderate level of difficulty rather than easy. Participants liked the layout, the information presented, the presentation of the prognostic information, and the values clarification exercise. Some overall suggestions included making navigation easier by repositioning certain buttons and adding a website content outline and additional resource links to the main page. An overview of the final version of the tool content and graphics is shown in Additional file
2.
Discussion
We described the development of Understanding Stroke: A Guide for Family Decision Makers, a web-based decision support tool for surrogate decision makers of stroke patients. The tool was developed through a rigorous process that involved a PFAC, four focus groups, a multidisciplinary study team, card sorting by volunteer patients and family members, and two rounds of usability testing. The tool received positive feedback during usability testing, and most individuals found the content helpful and the website easy to use. The text was rated as an 8th grade reading level in the Flesch-Kincaid readability test.
The tool features tailored content that takes into account the patient’s stroke type and medical history, and displays information and prognostic calculator results accordingly. To be mindful of family members’ preferences for information, the tool also offers the option to not see the prognosis. Goals of treatment are explained in detail, and a values clarification exercise is available to help surrogate decision makers determine what the patient would want in accordance with their values. Lastly, the tool summarizes key information from the interactive components and compiles a report which can be printed out by the family member.
Previous decision support tools addressing decisions on life-sustaining treatments have primarily focused on advanced care planning [
12,
27,
34,
35] with relatively few tools designed for use during an acute inpatient hospitalization. Other tools designed for use during an acute hospitalization have been developed for traumatic brain injury [
36] and prolonged mechanical ventilation [
9,
13,
37]. A recent pilot testing of a decision aid for prolonged mechanical ventilation suggested some improved outcomes, including lower physician-surrogate discordance for expected patient survival, greater comprehension, and improved quality of communication post-intervention [
9]. However, a larger randomized trial of the web-based version did not confirm the benefits other than observing a small reduction in decision conflict in the intervention group [
37]. Our tool shares many features with this web-based tool, including the utilization of a prognostic model and visual display of results, a values clarification exercise that focuses on goals of treatment decisions, additional questions for the care team, and a summary report that compiles key information. However, the differences in disease context, intended timeframe of use, and our different design of the values clarification exercise suggests a separate study of
Understanding Stroke is still warranted. In a systematic review done by Witteman et al., it was noted that there is a wide variety of design features in current values clarification tools, and more work is needed to evaluate their effects [
38,
39].
Understanding Stroke is currently being pilot tested in a non-randomized trial of 50 surrogate decision makers, with 25 each in a historical control group and intervention group. Enrollment of the control group began in February, 2018, concurrent with the development of
Understanding Stroke. Participants completed a baseline survey and a 1-month follow-up survey. For those in the intervention group, the website is shown on a tablet computer immediately following the baseline survey, followed by a post-intervention survey with tool-specific questions. Registration of this trial can be found on
ClinicalTrials.gov (
NCT03427645) [
40].
There are several limitations to the current version of
Understanding Stroke worth noting. One is that the tool focuses primarily on informational needs and does not address the emotional needs of surrogate decision makers. Other studies have shown that surrogates of seriously ill individuals have considerable need for emotional support [
37,
41‐
43]. However, this tool is in the early development stage. A future version could incorporate more comprehensive interventions that include both information and emotional support to family members. Secondly, the modified Rankin Scale was selected as the outcome because of its broad availability and use in stroke patients. There were concerns among the participants that the mRS would not convey the different types of disability, such as cognitive or speech impairment, and that different readers could interpret the information differently. Future work should address stroke prognostic models with a broader range of outcomes that may be more meaningful to patients and families. The tool also lacks a physician-facing component or direct integration into clinicians’ workflow. This design was by choice, in part to simplify the development and implementation of the initial version of the tool. Here again, a future version could be adapted to include a physician facing component or more direct integration into the clinical workflow. Lastly, although the tool was developed by following user-centered design principles, potential future enhancement could be realized through an experience-based co-design process that more actively involves participants in re-imagining the current decision aid with the support of a trained facilitator [
44]. Such a redesign should take into consideration the overall outcomes of the current tool and seek to improve that experience.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.